Glaukos Featured in Numerous Scientific Abstracts at ASCRS

Glaukos announced that its technologies will be featured in various scientific programming at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, being held July 23–27, 2021 in Las Vegas.

In addition, Glaukos is sponsoring an educational symposium in conjunction with ASCRS and EyeWorld entitled “Innovation & Transformation in Glaucoma Management – The iStent inject W: A Premium Solution” on Friday, July 23, 2021, at 5:00-6:00 pm PDT in Rooms L and GH at the Mandalay Bay South Convention Center. The faculty includes Richard Lindstrom, MD (Moderator); Mark Gallardo, MD; Leon Herndon, MD; Deborah Ristvedt, DO; and Thomas Samuelson, MD. Go here for more information and to register.

Key Glaucoma Presentations:

• Zachary C. Dockter
  Implantation of Two Second-Generation Trabecular Micro-Bypass Stents with Cataract Extraction in Open-Angle Glaucoma: Two-Year Outcomes

• Zachary C. Dockter
  Trabecular Micro-Bypass Stent Implantation with Cataract Extraction in Primary Open-Angle Glaucoma: Long-Term Results

• Tanner J. Ferguson, MD
  Trabecular Micro-Bypass Stent Implantation with Cataract Extraction in Pseudoexfoliative Glaucoma: Seven-Year Results

• Mark J. Gallardo, MD

Implantation of Trabecular Micro-Bypass Stents in Combination with Cataract Surgery in Open-Angle Glaucoma: Reduced IOP & Medication Burden

• Benjamin L. Heller, DO
  Real-World Outcomes of Second-Generation Trabecular Micro-Bypass Stent Implantation with Cataract Surgery in Primary Open-Angle Glaucoma

• Jeremy Hu, FRCOphth
  Combined iStent inject with Cataract Extraction in Asian Eyes with Primary Open-Angle Glaucoma: One-Year Outcomes

• John Kan, MBBS
  12-Month Outcomes of Combined Phacoemulsification and iStent inject in Asian Eyes with Normal-Tension Glaucoma: A Single-Centre Experience

• Karsten Klabe, MD
  Minimally-Invasive Glaucoma Surgery: Five-Years – Results with the iStent Inject

• Sophia S. Lam
  Outcomes of Second-Generation Trabecular Micro-Bypass Stent (iStent inject) Combined with Phacoemulsification in Open-Angle Glaucoma

• Brian Nguyen, DO
  Trabecular Micro-Bypass Stents as First-Line Intervention in Eyes with and without Prior Medication Usage

• Leela Raju, MD
  An Evaluation of Three Minimally-Invasive Glaucoma Surgeries (MIGS) Combined with Phacoemulsification for Treatment of Open-Angle Glaucoma

• Ali Salimi, MD, MSc
  Comparative Evaluation of Cataract Surgery with and without Trabecular Micro-Bypass Stents in Primary Angle-Closure Glaucoma: One-Year Results

• Ali Salimi, MD, MSc
  Three-Year Outcomes of Second-Generation Trabecular Micro-Bypass Stents (iStent inject) with Phacoemulsification in Various Glaucoma Subtypes

• Steven R. Sarkisian Jr., MD
  Reduction in IOP and Medication Burden Following Second-Generation Trabecular Micro- Bypass Stent Implantation with Concurrent Cataract Surgery

• Harrison J. Shawa
  Longitudinal U.S. Experience with First- and Second-Generation Trabecular Meshwork Micro-Bypass Stents in Combination with Cataract Surgery

• Mitchell C. Shultz, MD, ABO

U.S. Experience with Second-Generation Trabecular Micro-Bypass Implantation with Cataract Surgery, Either with or without Ab-Interno Canaloplasty

Key Corneal Health Presentations:

• Steven A. Greenstein, MD
  Ten-Year Follow-Up for Corneal Collagen Cross-Linking in Patients with Keratoconus and Post-Refractive Ectasia

• Abby Nieuwsma, MD
  Corneal Cross-Linking Outcomes in Patients with Thin Corneas: Can We Help More Patients with Keratectasia?

• Solin Saleh, MD

Outcomes of Corneal Cross-Linking for Keratoconus in a Pediatric Population

Abstracts and full session details can be found at www.ascrs.org.

Glaukos will also be exhibiting on the showroom floor throughout ASCRS at booth #3025.